Filing Details
- Accession Number:
- 0001209191-18-060179
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-11-28 20:51:03
- Reporting Period:
- 2018-11-26
- Accepted Time:
- 2018-11-28 20:51:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1305253 | Eiger Biopharmaceuticals Inc. | EIGR | Biological Products, (No Disgnostic Substances) (2836) | 361004130 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1686952 | Iii C. Eldon Mayer | C/O Eiger Biopharmaceuticals, Inc. 2155 Park Boulevard Palo Alto CA 94306 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-11-26 | 7,500 | $9.75 | 7,500 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-11-27 | 7,500 | $9.92 | 15,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2001-11-28 | 6,000 | $10.07 | 21,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $9.57 to $9.99 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1, 2 and 3 to this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $9.77 to $10.09 inclusive.
- The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $9.7495 to $10.26 inclusive.
Billionaire Hedge Funds
